Peripheral T-cell Lymphomas: Updates in Allogeneic Hematopoietic Stem Cell Transplantation

被引：3
作者：
Huang, Wen-Rong [1 ]
Liu, Dai-Hong [1 ]
机构：
[1] Chinese Peoples Liberat Army Gen Hosp, Dept Hematol, Beijing 100853, Peoples R China
来源：
CHINESE MEDICAL JOURNAL | 2018年 / 131卷 / 17期
关键词：
Allogeneic; Hematopoietic Stem Cell Transplantation; Peripheral T-cell Lymphoma; Survival; NON-HODGKIN-LYMPHOMA; MARROW TRANSPLANTATION; WORKING PARTY; SINGLE-CENTER; RELAPSE; SURVIVAL; BLOOD; EXPERIENCE; OUTCOMES; REGISTRY;
D O I：
10.4103/0366-6999.239315
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Objective: Peripheral T-cell lymphomas (PTCLs) confer dismal prognosis and no consensus has been established on the role of allogeneic hematopoietic stem cell transplantation (allo-HSCT) due to its rarity and heterogeneity. The purpose was to review key points of allo-HSCT for PTCLs, including indication, times of transplantation, conditioning regimen, graft versus host disease prophylaxis, and treatment of relapse. Data Sources: A comprehensive search in PubMed and Cochrane up to February 28, 2018, with the keywords "Peripheral", "T", "Lymphoma", and "Transplantation" was done. Study Selection: Relevant articles including HSCT for PTCLs were carefully reviewed. Results: Promising data have been reported from advances in transplant technology and more and more PTCLs patients with poor prognosis could benefit from allo-HSCT. Conclusion: Allo-HSCT is a useful choice for patients with refiactory/relapsed PTCLs or high-risk new diagnosed PTCLs.
引用
收藏
页码：2105 / +
页数：8
相关论文
共 35 条
  • [1] Racial Patterns of Peripheral T-Cell Lymphoma Incidence and Survival in the United States
    Adams, Scott V.
    Newcomb, Polly A.
    Shustov, Andrei R.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (09) : 963 - +
  • [2] Allogeneic transplantation with reduced-intensity conditioning for Hodgkin and non-Hodgkin lymphoma: Importance of histology for outcome
    Armand, Philippe
    Kim, Haesook T.
    Ho, Vincent T.
    Cutler, Corey S.
    Koreth, John
    Antin, Joseph H.
    LaCasce, Ann S.
    Jacobsen, Eric D.
    Fisher, David C.
    Brown, Jennifer R.
    Canellos, George P.
    Freedman, Arnold S.
    Soiffer, Rohert J.
    Alyea, Edwin P.
    [J]. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2008, 14 (04) : 418 - 425
  • [3] Defining the Intensity of Conditioning Regimens: Working Definitions
    Bacigalupo, Andrea
    Ballen, Karen
    Rizzo, Doug
    Giralt, Sergio
    Lazarus, Hillard
    Ho, Vincent
    Apperley, Jane
    Slavin, Shimon
    Pasquini, Marcelo
    Sandmaier, Brenda M.
    Barrett, John
    Blaise, Didier
    Lowski, Robert
    Horowitz, Mary
    [J]. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2009, 15 (12) : 1628 - 1633
  • [4] Primary nasal natural killer cell lymphoma: long-term treatment outcome and relationship with the International Prognostic Index
    Chim, CS
    Ma, SY
    Au, WY
    Choy, C
    Lie, AKW
    Liang, R
    Yau, CC
    Kwong, YL
    [J]. BLOOD, 2004, 103 (01) : 216 - 221
  • [5] Intensified chemo-immunotherapy with or without stem cell transplantation in newly diagnosed patients with peripheral T-cell lymphoma
    Corradini, P.
    Vitolo, U.
    Rambaldi, A.
    Miceli, R.
    Patriarca, F.
    Gallamini, A.
    Olivieri, A.
    Benedetti, F.
    Todeschini, G.
    Rossi, G.
    Salvi, F.
    Bruno, B.
    Baldini, L.
    Ferreri, A.
    Patti, C.
    Tarella, C.
    Pileri, S.
    Dodero, A.
    [J]. LEUKEMIA, 2014, 28 (09) : 1885 - 1891
  • [6] Graft-versus-lymphoma effect in relapsed peripheral T-cell non-Hodgkin's lymphomas after reduced-intensity conditioning followed by allogeneic transplantation of hematopoietic cells
    Corradini, P
    Dodero, A
    Zallio, F
    Caracciolo, D
    Casini, M
    Bregni, M
    Narni, F
    Patriarca, F
    Boccadoro, M
    Benedetti, F
    Rambaldi, A
    Gianni, AM
    Tarella, C
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (11) : 2172 - 2176
  • [7] Up-Front Autologous Stem-Cell Transplantation in Peripheral T-Cell Lymphoma: NLG-T-01
    d'Amore, Francesco
    Relander, Thomas
    Lauritzsen, Grete F.
    Jantunen, Esa
    Hagberg, Hans
    Anderson, Harald
    Holte, Harald
    Osterborg, Anders
    Merup, Mats
    Brown, Peter
    Kuittinen, Outi
    Erlanson, Martin
    Ostenstad, Bjorn
    Fagerli, Unn-Merete
    Gadeberg, Ole V.
    Sundstrom, Christer
    Delabie, Jan
    Ralfkiaer, Elisabeth
    Vornanen, Martine
    Toldbod, Helle E.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (25) : 3093 - 3099
  • [8] Allogeneic transplantation following a reduced-intensity conditioning regimen in relapsed/refractory peripheral T-cell lymphomas: long-term remissions and response to donor lymphocyte infusions support the role of a graft-versus-lymphoma effect
    Dodero, A.
    Spina, F.
    Narni, F.
    Patriarca, F.
    Cavattoni, I.
    Benedetti, F.
    Ciceri, F.
    Baronciani, D.
    Scime, R.
    Pogliani, E.
    Rambaldi, A.
    Bonifazi, F.
    Dalto, S.
    Bruno, B.
    Corradini, P.
    [J]. LEUKEMIA, 2012, 26 (03) : 520 - 526
  • [9] Real-world data on prognostic factors and treatment in peripheral T-cell lymphomas: a study from the Swedish Lymphoma Registry
    Ellin, Fredrik
    Landstrom, Jenny
    Jerkeman, Mats
    Relander, Thomas
    [J]. BLOOD, 2014, 124 (10) : 1570 - 1577
  • [10] Allogeneic hematopoietic stem cell transplantation for advanced extranodal natural killer/T-cell lymphoma, nasal type
    Ennishi, Daisuke
    Maeda, Yoshinobu
    Fujii, Nobuharu
    Kondo, Eisei
    Shinagawa, Katsuji
    Ikeda, Kazuma
    Ichimura, Koichi
    Yoshino, Tadashi
    Tanimoto, Mitsune
    [J]. LEUKEMIA & LYMPHOMA, 2011, 52 (07) : 1255 - 1261
1234